🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Real-world clinical outcomes and toxicity data will be evaluated in patient...
Status
Unknown
Location
Adamantia Nikolaidi
Start Date
2019-11-01
Trial ID
NCT04724031
Treatments Being Tested
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
This is the first-in-human clinical study of TQB3122, aiming to evaluate th...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2026-01-22
Trial ID
NCT07269145
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
The human epidermal growth factor receptor 2 (HER2) regulates cell growth a...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-09-06
Trial ID
NCT03368729
Treatments Being Tested
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested
This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-06-26
Trial ID
NCT03901469
Treatments Being Tested
Background: \- The new drug BMN 673 (talazoparib) has been shown to fight ...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-03-02
Trial ID
NCT02326844
Treatments Being Tested
Avelumab in combination with talazoparib will be investigated in patients w...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2017-10-19
Trial ID
NCT03330405
Treatments Being Tested